318 related articles for article (PubMed ID: 10905482)
1. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.
Stoffers DA; Kieffer TJ; Hussain MA; Drucker DJ; Bonner-Weir S; Habener JF; Egan JM
Diabetes; 2000 May; 49(5):741-8. PubMed ID: 10905482
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.
Xu G; Stoffers DA; Habener JF; Bonner-Weir S
Diabetes; 1999 Dec; 48(12):2270-6. PubMed ID: 10580413
[TBL] [Abstract][Full Text] [Related]
3. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.
Abraham EJ; Leech CA; Lin JC; Zulewski H; Habener JF
Endocrinology; 2002 Aug; 143(8):3152-61. PubMed ID: 12130581
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors.
Zhou J; Pineyro MA; Wang X; Doyle ME; Egan JM
J Cell Physiol; 2002 Sep; 192(3):304-14. PubMed ID: 12124776
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
Perfetti R; Zhou J; Doyle ME; Egan JM
Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273
[TBL] [Abstract][Full Text] [Related]
8. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 increases glucose-dependent activity of the homeoprotein IDX-1 transactivating domain in pancreatic beta-cells.
Hussain MA; Habener JF
Biochem Biophys Res Commun; 2000 Aug; 274(3):616-9. PubMed ID: 10924326
[TBL] [Abstract][Full Text] [Related]
10. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.
Li Y; Cao X; Li LX; Brubaker PL; Edlund H; Drucker DJ
Diabetes; 2005 Feb; 54(2):482-91. PubMed ID: 15677506
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells.
Hui H; Wright C; Perfetti R
Diabetes; 2001 Apr; 50(4):785-96. PubMed ID: 11289043
[TBL] [Abstract][Full Text] [Related]
12. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.
Tourrel C; Bailbe D; Lacorne M; Meile MJ; Kergoat M; Portha B
Diabetes; 2002 May; 51(5):1443-52. PubMed ID: 11978641
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1.
Doyle ME; Egan JM
Recent Prog Horm Res; 2001; 56():377-99. PubMed ID: 11237222
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.
List JF; Habener JF
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E875-81. PubMed ID: 15140754
[TBL] [Abstract][Full Text] [Related]
15. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
Hui H; Yu R; Bousquet C; Perfetti R
Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
[TBL] [Abstract][Full Text] [Related]
16. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
17. The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism.
Holst JJ; Orskov C
Diabetes; 2004 Dec; 53 Suppl 3():S197-204. PubMed ID: 15561911
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog signaling regulation of homeodomain protein islet duodenum homeobox-1 expression in pancreatic beta-cells.
Thomas MK; Lee JH; Rastalsky N; Habener JF
Endocrinology; 2001 Mar; 142(3):1033-40. PubMed ID: 11181516
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
Chepurny OG; Holz GG
Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
